Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» fenebrutinib
fenebrutinib
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Genentech
Roche
MS
multiple sclerosis
fenebrutinib
clinical trials
Roche’s BTK inhibitor succeeds in a Phase II MS trial
Clinical Trials Arena
Wed, 05/17/23 - 10:07 am
Roche
fenebrutinib
clinical trials
MS
relapsing multiple sclerosis